Baird Financial Group’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-35,859
| Closed | -$1.17M | – | 1760 |
|
|
2024
Q2 | $1.17M | Buy |
35,859
+3,638
| +11% | +$118K | ﹤0.01% | 1116 |
|
|
2024
Q1 | $812K | Buy |
+32,221
| New | +$812K | ﹤0.01% | 1222 |
|
|
2023
Q4 | – | Sell |
-23,274
| Closed | -$634K | – | 1725 |
|
|
2023
Q3 | $634K | Buy |
+23,274
| New | +$634K | ﹤0.01% | 1251 |
|
|
2023
Q2 | – | Sell |
-21,841
| Closed | -$473K | – | 1699 |
|
|
2023
Q1 | $473K | Buy |
21,841
+4,773
| +28% | +$103K | ﹤0.01% | 1335 |
|
|
2022
Q4 | $347K | Buy |
17,068
+7,651
| +81% | +$156K | ﹤0.01% | 1410 |
|
|
2022
Q3 | $241K | Buy |
+9,417
| New | +$241K | ﹤0.01% | 1539 |
|
|
2019
Q4 | – | Sell |
-127,828
| Closed | -$1.81M | – | 1512 |
|
|
2019
Q3 | $1.81M | Sell |
127,828
-19,108
| -13% | -$270K | 0.01% | 802 |
|
|
2019
Q2 | $1.64M | Buy |
+146,936
| New | +$1.64M | 0.01% | 836 |
|